Eagle Pharmaceuticals (FRA:1E6) Accumulated Depreciation : €-6.3 Mil (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Eagle Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Eagle Pharmaceuticals's quarterly accumulated depreciation increased from Dec. 2022 (€-6.2 Mil) to Mar. 2023 (€-6.3 Mil) and increased from Mar. 2023 (€-6.3 Mil) to Jun. 2023 (€-6.3 Mil).

Eagle Pharmaceuticals's annual accumulated depreciation increased from Dec. 2020 (€-4.3 Mil) to Dec. 2021 (€-5.3 Mil) and increased from Dec. 2021 (€-5.3 Mil) to Dec. 2022 (€-6.2 Mil).

Eagle Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Eagle Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eagle Pharmaceuticals Accumulated Depreciation Chart

Eagle Pharmaceuticals Annual Data

Trend

Sep13

Sep14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accumulated Depreciation

Get a 7-Day Free Trial

-2.94

-3.89

-4.27

-5.27

-6.23

Eagle Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Accumulated Depreciation	Get a 7-Day Free Trial															-5.96	-6.53	-6.23	-6.27	-6.30

Eagle Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Eagle Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Eagle Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Eagle Pharmaceuticals (FRA:1E6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eagle Pharmaceuticals Inc (FRA:1E6) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

EGRX:USA

Address

50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ, USA, 07677

Website

http://www.eagleus.com

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Eagle Pharmaceuticals (FRA:1E6) Headlines

No Headlines